GPT Healthcare Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is 5.17% vs 1.05% in Dec 2025

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 55.50% vs -11.60% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 12.84% vs -8.97% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is -3.54% vs 4.63% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of GPT Healthcare With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

126.37

82.06

44.31

54.00%

Other Operating Income

0.00

Total Operating income

126.37

82.06

44.31

54.00%

Raw Material Cost

23.40

3.79

19.61

517.41%

Purchase of Finished goods

0.00

7.80

-7.80

-100.00%

(Increase) / Decrease In Stocks

0.00

-0.14

0.14

100.00%

Employee Cost

22.21

17.57

4.64

26.41%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

57.39

28.28

29.11

102.93%

Total Expenditure (Excl Depreciation)

103.00

57.30

45.70

79.76%

Operating Profit (PBDIT) excl Other Income

23.37

24.76

-1.39

-5.61%

Other Income

1.63

1.13

0.50

44.25%

Operating Profit (PBDIT)

25.00

25.89

-0.89

-3.44%

Interest

2.18

2.07

0.11

5.31%

Exceptional Items

0.00

Gross Profit (PBDT)

22.82

23.82

-1.00

-4.20%

Depreciation

6.95

5.34

1.61

30.15%

Profit Before Tax

15.86

18.48

-2.62

-14.18%

Tax

1.30

4.75

-3.45

-72.63%

Provisions and contingencies

0.00

Profit After Tax

14.57

13.73

0.84

6.12%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

14.57

13.73

0.84

6.12%

Equity Capital

82.05

16.31

65.74

403.07%

Face Value

10.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

1.78

0.84

0.94

111.90%

Diluted Earnings per share

1.78

0.84

0.94

111.90%

Operating Profit Margin (Excl OI)

18.49%

30.17%

0.00

-11.68%

Gross Profit Margin

18.06%

29.03%

0.00

-10.97%

PAT Margin

11.53%

16.73%

0.00

-5.20%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 126.37 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 5.17% vs 1.05% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 24.63% vs 1.98% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 14.57 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 55.50% vs -11.60% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 13.03% vs 0.55% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 23.37 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 12.84% vs -8.97% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 12.95% vs -10.74% in Mar 2025

Quarterly - Interest

Interest 2.18 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -3.54% vs 4.63% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 113.73% vs -35.85% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 18.49%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025